ArticleScience advances2026
Suspended particles for omnidirectional template sacrifice for rapid vascular patterning within engineered tissues.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Engineered tissues offer great promise for therapeutic organ repair. Yet, biofabrication of organ-scale tissues can take hours or days for large constructs with geometric complexity, during which living cells in the construct lack vascular support. To address this, we developed an approach to accelerate biofabrication by embedding microreservoirs of evacuation reagents throughout geometrically patterned sacrificial agents. We call this approach Suspended Particles for Omnidirectional Template Sacrifice (SPOTS). We show that microparticles can serve as both structural impurities as well as depots for dissolution agents within sacrificial materials, both of which facilitate accelerated degradation of sacrificial materials and vascular templates. We used SPOTS to produce branched vascular networks in engineered tissue constructs. These networks support perfusion and endothelialization, improve the viability of human cells embedded in the construct, and support phenotype and function of human hepatocytes in the surrounding matrix. By accelerating biofabrication processes, SPOTS thus addresses a critical remaining challenge hindering translation of engineered tissues.
Indexed as
Identifiers
42826194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.